Skip to main content

Erythromycin

ADVERTISEMENT
Identification
Molecular formula
C37H67NO13
CAS number
114-07-8
IUPAC name
2-[9-[4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-3-ethyl-7-hydroxy-2,8,12,16-tetramethyl-5,13-dioxo-4,17-dioxabicyclo[14.1.0]heptadec-14-en-10-yl]acetaldehyde
State
State

In its pure form, erythromycin is typically a solid at room temperature. It may be present in powdered or crystalline form.

Melting point (Celsius)
135.00
Melting point (Kelvin)
408.15
Boiling point (Celsius)
806.50
Boiling point (Kelvin)
1 079.65
General information
Molecular weight
733.94g/mol
Molar mass
733.9370g/mol
Density
1.2430g/cm3
Appearence

Erythromycin is a white to off-white crystalline powder. It may appear as small colorless crystals and is known for its bitter taste. This compound is sensitive to light and moisture.

Comment on solubility

Solubility of 2-[9-[4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-3-ethyl-7-hydroxy-2,8,12,16-tetramethyl-5,13-dioxo-4,17-dioxabicyclo[14.1.0]heptadec-14-en-10-yl]acetaldehyde

The solubility of the compound with the formula C37H67NO13 can be examined through various factors influenced by its intricate structure. This compound exhibits a significant degree of complexity, which plays a crucial role in determining its solubility profile.

Factors Affecting Solubility

  • Polarity: Compounds with polar functional groups tend to be more soluble in polar solvents, while non-polar parts may dissolve better in non-polar solvents.
  • Molecular Size: The large molecular size and complexity of this compound may hinder its solubility in certain solvents due to steric effects.
  • Hydrogen Bonding: The presence of hydroxyl groups suggests the potential for hydrogen bonding, which can enhance solubility in water.

Overall, solubility can be described as:

  • Good solubility in polar solvents due to hydrogen bonding capability.
  • Limited solubility in non-polar solvents as a result of its larger and more complex non-polar segments.

In practical applications, the solubility of this compound is essential for its efficacy and behavior in various environments. It is recommended to conduct solubility tests across different solvents to fully understand its behavior.

Interesting facts

Interesting Facts about 2-[9-[4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-3-ethyl-7-hydroxy-2,8,12,16-tetramethyl-5,13-dioxo-4,17-dioxabicyclo[14.1.0]heptadec-14-en-10-yl]acetaldehyde

This compound, known for its complex structure, offers a fascinating glimpse into the realm of organic chemistry. Here are some intriguing aspects:

  • Diverse Functional Groups: The presence of dimethylamino, hydroxy, and multiple ketone groups makes it a versatile molecule, enhancing its reactivity and potential applications.
  • Tetrahydropyran Ring: The tetrahydropyran moiety adds to the compound's stability and influences its interaction with biological systems, making it noteworthy in medicinal chemistry.
  • Potential Applications: Given its structure, this compound may exhibit properties that are useful in pharmaceuticals or agricultural sciences, such as acting as a **bioactive agent** or **chemical intermediate**.
  • Impact on Research: Molecules with intricate structures like this one often lead to novel findings and discoveries, pushing the boundaries of what we understand about biochemical interactions.
  • Synthesis Challenges: The multi-step synthesis of such compounds requires innovative approaches and techniques in organic chemistry, illustrating the complexity of modern chemical synthesis.

As a student or scientist, one could marvel at the intricate dance of atoms within this compound. The variations in its synthesis and the exploration of its chemical properties can pave the way for groundbreaking research. Indeed, as one dives deeper into the study of such compounds, one might echo the words of a renowned chemist: "Chemistry is the art of transformation, revealing the hidden potential in every molecule."

Synonyms
ROSAMICIN
35834-26-5
DTXSID00860525
3-Ethyl-7-hydroxy-2,8,12,16-tetramethyl-5,13-dioxo-10-(2-oxoethyl)-4,17-dioxabicyclo[14.1.0]heptadec-14-en-9-yl 3,4,6-trideoxy-3-(dimethylamino)hexopyranoside
NCI60_001431